Related references
Note: Only part of the references are listed.'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry
E. D. Virus et al.
JOURNAL OF MASS SPECTROMETRY (2012)
Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer
Hirokuni Ikeda et al.
CANCER SCIENCE (2011)
Dual effects of estrogen on vascular smooth muscle cells: Receptor-mediated proliferative vs. metabolite-induced pro-senescent actions
Liang Zhang et al.
STEROIDS (2011)
Differential Pulse Voltammetric Determination of Fulvestrant in Pharmaceutical Dosage Forms and Serum Samples
Dilek Kul et al.
INTERNATIONAL JOURNAL OF ELECTROCHEMISTRY (2011)
Supercritical fluid chromatography for the 21st century
Larry T. Taylor
JOURNAL OF SUPERCRITICAL FLUIDS (2009)
Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells
Barbara C. Spink et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells
Leane Lehmann et al.
CARCINOGENESIS (2008)
Analysis of a challenging subset of world anti-doping agency-banned steroids and antiestrogens by LC-MS-MS
Chad R. Borges et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2007)
Application of the principles of green chemistry in analytical chemistry
Mihkel Koel et al.
PURE AND APPLIED CHEMISTRY (2006)
Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer
JFR Robertson et al.
CLINICAL PHARMACOKINETICS (2004)
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women - A prospective combined analysis of two multicenter trials
JFR Robertson et al.
CANCER (2003)
Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor
DN Grigoryev et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2000)
Share Paper
